Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody-Mediated Graft Rejection”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Testing effectiveness (Phase 2)Study completedNCT01873157
What this trial is testing

Bortezomib in Late Antibody-mediated Kidney Transplant Rejection

Who this might be right for
Late Rejection of Renal TransplantAntibody-mediated Rejection
Medical University of Vienna 44
Not applicableNot Yet RecruitingNCT07005687
What this trial is testing

Using MSCs for Chronic Active Antibody Mediated Rejection

Who this might be right for
Kidney Transplant Rejection
Shahid Beheshti University of Medical Sciences 10
Not applicableLooking for participantsNCT07006532
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab

Who this might be right for
Kidney Transplant Rejection
Shahid Beheshti University of Medical Sciences 50
Not applicableLooking for participantsNCT06112951
What this trial is testing

A Prospective Randomized Trial of ECP in Subclinical AMR

Who this might be right for
Antibody-mediated RejectionLung Transplant Rejection
Medical University of Vienna 80
Not applicableUnknownNCT04414735
What this trial is testing

Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Fundacion Clinic per a la Recerca Biomédica 30
Early research (Phase 1)Looking for participantsNCT06990711
What this trial is testing

Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation

Who this might be right for
Antibody Mediated Rejection of Lung Transplant
Washington University School of Medicine 30
Large-scale testing (Phase 3)Ended earlyNCT03994783
What this trial is testing

Transplant Antibody-Mediated Rejection: Guiding Effective Treatments

Who this might be right for
Kidney Transplant RejectionAntibody-mediated Rejection
Imperial College London 3
Early research (Phase 1)Looking for participantsNCT06918990
What this trial is testing

Treatment of Antibody-Mediated Rejection (ABMR) With CarBel

Who this might be right for
Kidney Transplant Rejection
National Institute of Allergy and Infectious Diseases (NIAID) 25
Testing effectiveness (Phase 2)WithdrawnNCT03805178
What this trial is testing

Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization

Who this might be right for
Lung Transplant RejectionAntibody-mediated Rejection
Duke University
Not applicableUnknownNCT05779124
What this trial is testing

BAFF/APRIL in Kidney Transplant Rejection Risk Assessment

Who this might be right for
Kidney TransplantationKidney Transplant Rejection
First Affiliated Hospital, Sun Yat-Sen University 176
Testing effectiveness (Phase 2)Study completedNCT01147302
What this trial is testing

A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated Rejection

Who this might be right for
Graft Rejection
Shire 18
Testing effectiveness (Phase 2)Study completedNCT00771875
What this trial is testing

Randomized Trial for Mixed Acute Rejection

Who this might be right for
Graft Rejection
University of Cincinnati 30
Not applicableStudy completedNCT03393793
What this trial is testing

HEart trAnsplantation Registry of piTie-Salpetriere University Hospital

Who this might be right for
Cardiac Transplant DisorderCardiac DeathHeart Failure+5 more
Lee S Nguyen 566
Testing effectiveness (Phase 2)Study completedNCT04204980
What this trial is testing

Desensitization in Kidney Allograft Using Daratumumab

Who this might be right for
AllosensitizationKidney Transplant RejectionAntibody-mediated Rejection
Assistance Publique - Hôpitaux de Paris 21
Not applicableUnknownNCT04368962
What this trial is testing

DSA Risk Factors in MMF-based Immunosuppressed Post-transplanted Patients

Who this might be right for
Antibody-mediated Rejection
First Affiliated Hospital Xi'an Jiaotong University 300
Not applicableStudy completedNCT04367610
What this trial is testing

Effects of A Standardized Treatment Approach on Kidney Transplant Recipients With Antibody-Mediated Rejection

Who this might be right for
Antibody-mediated RejectionKidney Transplant RejectionGraft Loss
Istanbul University 75
Not applicableActive Not RecruitingNCT03859388
What this trial is testing

Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection

Who this might be right for
Rejection Chronic RenalKidney Transplant Rejection
Cedars-Sinai Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT03380377
What this trial is testing

Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant

Who this might be right for
Antibody-mediated RejectionKidney Transplant; ComplicationsTransplant Glomerulopathy+3 more
Stanley Jordan, MD 10
Not applicableUnknownNCT03916822
What this trial is testing

Cell-based Assays for Antibody-mediated Transplant Rejection

Who this might be right for
Antibody-Mediated Graft Rejection
Plexision 30
Not applicableLooking for participantsNCT02812290
What this trial is testing

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

Who this might be right for
Lung Transplant Rejection
University of Alberta 700
Next Page